No Relapse of Calcineurin Inhibitor-Associated Thrombotic Microangiopathy after Discontinuation of Eculizumab

Acta Haematol. 2017;138(4):194-197. doi: 10.1159/000481724. Epub 2017 Nov 15.

Authors

Thomas Neumann¹, Andrzej Plis, Martin Weigel, Sylvia Stracke, Sigrun Friesecke, Stephanie-Susanne Stecher, Laila Schneidewind, Christoph Busemann, Christian Andreas Schmidt, William H Krüger

Affiliation

¹ Department of Internal Medicine C (Haematology and Oncology, Stem Cell Transplantation, Palliative Care), University Hospital Greifswald, Ernst-Moritz-Arndt University, Greifswald, Germany.

PMID: 29136616
DOI: 10.1159/000481724

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Allografts
Antibodies, Monoclonal, Humanized / administration & dosage*
Calcineurin Inhibitors / adverse effects*
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / therapy
Male
Middle Aged
Multiple Myeloma / therapy
Peripheral Blood Stem Cell Transplantation / adverse effects
Recurrence
Thrombotic Microangiopathies / blood
Thrombotic Microangiopathies / chemically induced*
Thrombotic Microangiopathies / therapy*

Substances

Antibodies, Monoclonal, Humanized
Calcineurin Inhibitors
eculizumab